Remdesivir Market

It is a nucleoside analog with antiviral activity, with an EC50 value of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and an EC50 value of 30 for murine hepatitis virus in delayed brain tumor cells nM.

Remdesivir Market contains market size and forecasts of Remdesivir in global, including the following market information:

• Global Remdesivir Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Remdesivir Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Remdesivir companies in 2021 (%)

The global Remdesivir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

• The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
• 10 mM*1 mL in DMSO Segment to Reach $ Million by 2028, with a % CAGR in next six years.
• The global key manufacturers of Remdesivir include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma and Hunan Warrant Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
• We surveyed the Remdesivir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Remdesivir Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Remdesivir Market Segment Percentages, by Type, 2021 (%)

• 10 mM*1 mL in DMSO
• 5mg
• 10mg
• 50mg
• 100mg

• Hospital
• Clinics
• Drug Store
• Others

Global Remdesivir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Remdesivir Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Remdesivir revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Remdesivir revenues share in global market, 2021 (%)
• Key companies Remdesivir sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Remdesivir sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences
• Bright Gene
• Hainan Haiyao
• Kelun Pharma
• Hunan Warrant Pharmaceutical